findmyKOL
Clinical trialNCT02689349CompletedInterventional

Esteem New Subject Enrollment Post Approval Study

SponsorEnvoy Medical CorporationEnrollment117Sensorineural Hearing Loss
View the registry record on ClinicalTrials.gov

Summary

The lay summary the sponsor registered on ClinicalTrials.gov.

The New Enrollment Post-Approval Study is designed to evaluate the safety and efficacy of the Esteem Totally Implantable Hearing System in subjects suffering from moderate to severe hearing loss.

Investigators

The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

6 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

United States
  • North Alabama Ent Associates

    Madison, Alabama, United States

  • Pacific Hearing Service

    Los Altos, California, United States

  • Ear, Nose, & Throat Associates of South Florida

    Jupiter, Florida, United States

  • Ear Consultants of Georgia

    Atlanta, Georgia, United States

  • Loyola Center for Hearing

    Woodridge, Illinois, United States

  • Oklahoma Otolaryngology Associates

    Norman, Oklahoma, United States

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

No drug or biological interventions are in our data for this study. It may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start
31 Aug 2010
Primary completion
30 Sept 2021
Completion
30 Sept 2021
Last update posted
27 Jun 2022
Registered enrollment
117
Registry id
NCT02689349

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 24 Aug 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.